<div dir="ltr">Thank you for this news.<br><div class="gmail_extra"><br><div class="gmail_quote">On Wed, Mar 1, 2017 at 3:46 PM, Richard Poynder <span dir="ltr"><<a href="mailto:rickypo@hotmail.co.uk" target="_blank">rickypo@hotmail.co.uk</a>></span> wrote:<br><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex">
<div link="#0563C1" vlink="#954F72" lang="EN-GB">
<div class="m_2536772237085725107WordSection1">
<p class="MsoNormal">Of note: this paywalled article reports that 51% of a random sample of non-OA articles on ResearchGate infringed the copyright and were non-compliant with publishers’ policy.<u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal"><a href="https://link.springer.com/article/10.1007/s11192-017-2291-4" target="_blank">https://link.springer.com/<wbr>article/10.1007/s11192-017-<wbr>2291-4</a><u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal">Amongst those to invest in the company were the Wellcome Trust. It would be interesting to hear more from Wellcome as to why it has invested in ResearchGate.<span class="HOEnZb"><font color="#888888"><u></u><u></u></font></span></p><span class="HOEnZb"><font color="#888888">
<p class="MsoNormal"><u></u></p></font></span></div></div></blockquote><div><br></div><div>I think this is very important for those who believe in universal access to the scientific literature and its re-use without restriction. The disturbing picture is that those with money and lawyers can "ignore" the details of copyright law, while individual scholars who are using the literature are disadvantaged by formally having to comply with copyright (which if broken is a legal offence).<br><br></div><div>I hope you can get a statement from Wellcome Trust to bring to this list.<br></div><div> </div><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex"><div link="#0563C1" vlink="#954F72" lang="EN-GB"><div class="m_2536772237085725107WordSection1"><span class="HOEnZb"><font color="#888888"><p class="MsoNormal"> <u></u></p>
<p class="MsoNormal">Richard Poynder<u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
</font></span></div>
</div>
<br>______________________________<wbr>_________________<br>
GOAL mailing list<br>
<a href="mailto:GOAL@eprints.org">GOAL@eprints.org</a><br>
<a href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal" rel="noreferrer" target="_blank">http://mailman.ecs.soton.ac.<wbr>uk/mailman/listinfo/goal</a><br>
<br></blockquote></div><br><br clear="all"><br>-- <br><div class="gmail_signature" data-smartmail="gmail_signature"><div dir="ltr"><div>Peter Murray-Rust<br>Reader Emeritus in Molecular Informatics<br>Unilever Centre, Dept. Of Chemistry<br>University of Cambridge<br>CB2 1EW, UK<br>+44-1223-763069</div></div></div>
</div></div>